DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the GUJARAT KIDNEY N SUP SP L (GKSL) share price today?

GUJARAT KIDNEY N SUP SP L (GKSL) is trading at ₹128.36 on the NSE, down 0.33% on the day. Source: DocStoX.

What is the PE ratio of GUJARAT KIDNEY N SUP SP L?

GUJARAT KIDNEY N SUP SP L has a price-to-earnings (PE) ratio of 65.2 in the Healthcare Services sector.

What is the market capitalisation of GUJARAT KIDNEY N SUP SP L?

GUJARAT KIDNEY N SUP SP L has a market capitalisation of approximately ₹1,009 crore.

GUJARAT KIDNEY N SUP SP L

GKSL·NSE·Healthcare Services

₹128.36▼ -0.42 (-0.33%)

Healthcare Services · Hospitals

A steady, established business

Day₹127.05

₹131.83

52W₹98

₹14860%

Open

₹128.99

High

₹131.83

Low

₹127.05

Prev Close

₹128.78

Volume

1.31L

VWAP

₹128.27

Snapshot

Key fundamentals

Market Cap

₹1,009 Cr

P/E Ratio

65.16Expensive

P/B Ratio

4.09

EPS

₹1.97

Book Value

₹32.00

ROE

11.10%Average

ROCE

14.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.11Low

Face Value

₹2.00

52W High

₹148.34

52W Low

₹98.36

Sector

Healthcare Services

Industry

Hospitals

Avoid

None moatMedium uncertainty

Fair value estimate

₹33

▼ 74.1%downside

Trading at ₹128 — 74% above our estimate

BearFair valueBull

₹28₹33₹38

/100

Business quality — Watch the fundamentals

Growth 50Profitability 65Efficiency 15Valuation 47

Plain English

Our view

A steady, established business
Low debt relative to equity
Expensive — trades at 65× earnings

Strengths

Low debt relative to equity
Promoters hold a controlling stake

Risks

Expensive — trades at 65× earnings
Fundamental red flags (Piotroski 0/9)

How we got there

Fair value methods

Residual income

11% ROE fading to 12% over ~3 yrs, on ₹32 book

₹32

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹38

Analyst target

No analyst coverage

—

Blended fair value₹33

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

Expensive — trades at 65× earnings
Fundamental red flags (Piotroski 0/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

65.2Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

11.1%Average

Above 15% is considered healthy for Indian equities

ROCE

14.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.11Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1,009 Cr

P/B

4.09

EPS

₹1.97

Div Yield

—

What changed

Recent changes

Foreign investors-5.6% stake last quarter
Domestic institutions-1.1% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 65.2×

Growth

N/A

No history

Profitability

Modest

11.1% ROE

Financial health

Rock solid

D/E 0.11

Momentum

N/A

No technicals

Today

Trading activity

Delivery %69.0%

Turnover₹167.77L Cr

Trades1,687

VWAP₹128.27

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

—

+136.9%

10Y

—

Profit

—

+192.1%

10Y

—

EPS

—

10Y

—

Profile

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 172 days.
Working capital days have increased from 55.7 days to 91.1 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 5.58 pts; domestic institutions reduced 1.11 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

71%

Promoter

Promoters

71.5%0.00

Public

23.1%+6.70

FII / FPI

4.9%-5.58

DII

0.6%-1.11

Total shareholders

18,301+18,294 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter71.45%

FII4.89%

DII0.56%

Public23.10%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]